BENRALIZUMAB (FASENRA) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

BENRALIZUMAB

What is the Trade Name for BENRALIZUMAB

FASENRA

What is the Indication for BENRALIZUMAB

  • 1 INDICATIONS AND USAGE FASENRA is indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype [see Clinical Studies (14) ] . Limitations of use: ‚Ä¢ FASENRA is not indicated for treatment of other eosinophilic conditions. ‚Ä¢ FASENRA is not indicated for the relief of acute bronchospasm or status asthmaticus. FASENRA is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. (1) Limitations of Use: ‚Ä¢ Not for treatment of other eosinophilic conditions. (1) ‚Ä¢ Not for relief of acute bronchospasm or status asthmaticus. (1)

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]